Organizes impact analysis meeting with the team members involved to propose solutions to the brand.
February 10, 2020
Reporting to the various participants is normalized according the product development team orientations (reporting to the brand and to the Head office).
January 24, 2020
Proposes solutions with the project actors to the brand.
January 15, 2020
Supports Regulatory in validation of Quantitative Ingredient list / INCIs.
December 15, 2019
Updates the activities and timings in the selected planning tool.
October 11, 2019
Works closely with the brands, the CDMOs, finance, supply chain, operations QRVi, and medical affairs to ensure that G1 and G2 decisions are respected.
September 15, 2019